Skip to content

Tolerance to Light for Patients Suffering From Keratitis

Tolerance to Light for Patients Suffering From Keratitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03586505
Acronym
EBLOUI
Enrollment
30
Registered
2018-07-13
Start date
2018-07-03
Completion date
2019-08-07
Last updated
2019-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratitis

Keywords

Keratitis, Eye Infection, Photophobia, Red light, Infrared light

Brief summary

In order to develop an innovative device to study infectious keratitis, we need to illuminate the cornea of patients suffering from an infectious keratitis with red or near-infrared light. Because of technical reasons the shortest possible wavelength (red) presents advantages.

Detailed description

The aim of this preliminary study is to measure the maximal intensity tolerated during illumination with 6 wavelength corresponding : 2 red, 2 far red and 1 near infrared lights in order to determine the shortest wavelength well tolerated by patients, in comparison with the standard blue light illumination.

Interventions

The 6 lights used randomly are : * 482nm =standard blue light illumination, * 650nm, * 675nm, * 700nm, * 750nm * 800nm

Sponsors

University of Saint-Etienne
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Each patient is its own control

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Social security insurance * Suspected infectious keratitis (clinically defined. No lab testing required) * Signed informed consent

Exclusion criteria

* Major Blepharospasm * Aphakia (absence of lens) * Pregnant woman * Nursing mother

Design outcomes

Primary

MeasureTime frameDescription
Light intensityAt the inclusionFor each wavelength, the highest light intensity tolerated by the patient is measured (mWatts/cm² )

Secondary

MeasureTime frameDescription
Severity of the keratitisAt the inclusionIt is determined by slit lamp. The result is severe or not severe

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026